Two weeks after fraudster Martin Shkreli filed a lawsuit against one of the biotechs he had founded — and been kicked out of — it’s over.
A spokesman for Retrophin told CNBC that they had resolved “all outstanding disputes between them.” And that includes the suit that Retrophin had brought against its former CEO three years ago, claiming that he had breached his fiduciary responsibility to the company.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,